Genetic susceptibility to lupus nephritis

Lupus

Volumn 7, Issue 9, 1998, Pages 585-590

  Tsao, B P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Association analysis; Candidate chromosomal region; Linkage analysis; Lupus nephritis; Susceptibility gene

Indexed keywords

FC RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; MANNOSE BINDING PROTEIN; PROTEIN BCL 2;

ARTICLE; CHROMOSOME 1Q; CHROMOSOME MAP; CLINICAL FEATURE; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; NEGRO; PRIORITY JOURNAL; SIBLING; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS;

EID: 0032447088     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678920695     Document Type: Article

References (33)

1. Bennett ST, Todd JA. Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet 1996; 30: 343-370.
2. Pericak-Vance MA, Haines JI. Genetic susceptibility to Alzheimer disease. Trends Genet 1995; 11: 504-508 (review).
3. Kotzin BL. Systemic lupus erythematosus. Cell 1996; 85: 303-306.
4. Arnett FC, Jr. The genetics of human lupus. In: Wallace DJ, Hahn BN (eds) Dubois' Lupus Erythematosus, 5th edn. Williams and Wilkins: Baltimore, 1997, pp 77-117.
5. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987; 40: 1-14.
6. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265: 2037-2048.
7. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996; 85: 311-318 (review).
8. Collins FS, Guyer MS, Chakravarti A. Variations on a theme: cataloging human DNA sequence variation. Science 1997; 278: 1580-1581.
9. Wallace DJ, Hahn BH, Klippel JH. Lupus nephritis. In: Wallace DJ, Hahn BH (eds) Dubois' Lupus Erythemalosus, 5th edn. Williams and Wilkins: Baltimore, 1997, pp 1053-1065.
10. Freedman BI et al. Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis 1997; 29: 729-732.
11. Schur PH. Complement and systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois' Lupus Erythematosus, 5th edn. Williams and Wilkins: Baltimore, 1997, pp 245-261.
12. Botto M et al. Homozygous CIq deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19: 56-59 (letter).
13. Vyse TJ, Kotzin BL. Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 1998; 16: 261-292 (review).
14. Carroll MC. The lupus paradox. Nat Genet 1998; 19: 3-4.
15. Korb LC, Ahearn JM. Cutting Edge. CIq binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 1997; 158: 4525-4528.
16. Cutler AJ et al. T cell-dependent immune response in C1q-deficient mice: defective Interferon γ production by antigen-specific T cells. J Exp Med 1998; 187: 1789-1797.
17. Duits AJ et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1995; 39: 1832-1836.
18. Salmon JE, Millard S, Schachter L. FcγRIIA alleles are heritable risk factors for lupus nephritis in African-Americans. J Clin Invest 1996; 97: 1348-1354.
19. Botto M et al. FcγRIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin Exp Immunol 1996; 104: 264-268.
20. Song YW et al. Abnormal distribution of FcgRIIa polymorphism in patients with systemic lupus erythematosus. Arthritis Rheum 1998; 43: 421-426.
21. Manger K et al. Fcγ receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms. Arthritis Rheum 1998; 41: 1181-1189.
22. Wu J et al. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; 100: 1059-1070.
23. Clynes R, Dumitru C, Ravetch JV. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 1998; 279: 1052-1054.
24. Daeron M. Fc receptor biology. Annu Rev Immunol 1997; 15: 203-234.
25. Ravetch JV, Clynes RA. Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 1998; 16: 421-432 (review).
26. Firestein GS. Etiology and pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB (eds) Textbook of Rheumatology; 5th edn. WB Saunders: Philadelphia, 1997, pp 851-897.
27. Reichlin M, Harley JB, Lockshin MD. Serologic studies of monozygotic twins with SLE. Arthritis Rheum 1992; 35: 457-464.
28. Mehrian R et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum 1998; 41: 596-602.
29. Ott J. Linkage analysis with disease loci. Analysis of Human Genetic Linkage, revised edn. Baltimore: Johns Hopkins University Press, 1991, pp 230-257.
30. Tsao BP et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997; 99(4): 725-731.
31. Tsao BP, Cantor RM, Badsha H, Grossman JM, Kalunian KC, Hartung K, Arnett FC, Wallace DJ, Hahn BH, Rotter JI. A susceptibility gene for SLE maps to a 5 cM region of chromosome 19. Arthritis Rheum 1997; 40: S315.
32. Kearns G et al. Three candidate SLE susceptibility loci on chromosome 1 identified by microsatellite gene mapping in 105 SLE-sibpair families. Arthritis Rheum 1997; 40: S315.
33. Moser KL et al. Scanning the genome for human SLE genes: design and candidate regions. Lupus 1998; 5: 13.